Chemoinformaics analysis of 4-Acetyloxybut-2-enyl acetate
Molecular Weight | 172.18 | nRot | 4 |
Heavy Atom Molecular Weight | 160.084 | nRig | 3 |
Exact Molecular Weight | 172.074 | nRing | 0 |
Solubility: LogS | -0.672 | nHRing | 0 |
Solubility: LogP | 0.83 | No. of Aliphatic Rings | 0 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 24 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 12 | No. of Aromatic Carbocycles | 0 |
nHetero | 4 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 12 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 8 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 4 | No. of Arom Bond | 0 |
nHA | 4 | APOL | 24.5695 |
nHD | 0 | BPOL | 17.2465 |
QED | 0.462 |
Synth | 2.478 |
Natural Product Likeliness | 0.902 |
NR-PPAR-gamma | 0.006 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Rejected |
Pgp-inh | 0.001 |
Pgp-sub | 0.001 |
HIA | 0.007 |
CACO-2 | -4.481 |
MDCK | 0.000216142 |
BBB | 0.96 |
PPB | 0.132 |
VDSS | 0.819 |
FU | 0.8396 |
CYP1A2-inh | 0.249 |
CYP1A2-sub | 0.075 |
CYP2c19-inh | 0.029 |
CYP2c19-sub | 0.14 |
CYP2c9-inh | 0.002 |
CYP2c9-sub | 0.167 |
CYP2d6-inh | 0.031 |
CYP2d6-sub | 0.157 |
CYP3a4-inh | 0.034 |
CYP3a4-sub | 0.249 |
CL | 4.689 |
T12 | 0.925 |
hERG | 0.02 |
Ames | 0.108 |
ROA | 0.03 |
SkinSen | 0.908 |
Carcinogencity | 0.733 |
EI | 0.983 |
Respiratory | 0.036 |
NR-Aromatase | 0.005 |
Antiviral | No |
Prediction | 0.929451 |